Blood coagulation and autologous blood transfusion in cardiac surgery.

[1]  S. Stenbjerg,et al.  Heparin levels and activated clotting time (ACT) during open heart surgery. , 2009, Scandinavian journal of haematology.

[2]  D. Collen.  Coronary thrombolysis: streptokinase or recombinant tissue-type plasminogen activator? , 1990, Annals of internal medicine.

[3]  A Ranhosky,et al.  The safety of intravenous dipyridamole thallium myocardial perfusion imaging. Intravenous Dipyridamole Thallium Imaging Study Group. , 1990, Circulation.

[4]  A. Keats,et al.  Low activated coagulation time during cardiopulmonary bypass does not increase postoperative bleeding. , 1990, The Annals of thoracic surgery.

[5]  M. Schechter,et al.  A trial of desmopressin (1-desamino-8-D-arginine vasopressin) to reduce blood loss in uncomplicated cardiac surgery. , 1989, The New England journal of medicine.

[6]  L. Goodnough,et al.  Increased preoperative collection of autologous blood with recombinant human erythropoietin therapy. , 1989, The New England journal of medicine.

[7]  F. Claas,et al.  Effect of one-HLA-DR-antigen-matched and completely HLA-DR-mismatched blood transfusions on survival of heart and kidney allografts. , 1989, The New England journal of medicine.

[8]  J. Branch,et al.  HEPARIN SENSITIVITY COMPARISON OF THE ACT, SCT, AND APTT , 1989 .

[9]  H. White,et al.  Effect of intravenous streptokinase as compared with that of tissue plasminogen activator on left ventricular function after first myocardial infarction. , 1989, The New England journal of medicine.

[10]  H. Reichenspurner,et al.  Blood platelets in cardiopulmonary bypass operations. Recovery occurs after initial stimulation, rather than continual activation. , 1989, The Journal of thoracic and cardiovascular surgery.

[11]  T. Lane,et al.  Apparent coagulopathy caused by infusion of shed mediastinal blood and its prevention by washing of the infusate. , 1989, The Annals of thoracic surgery.

[12]  D. Cosgrove,et al.  Reduction in blood loss and blood use after cardiopulmonary bypass with high dose aprotinin (Trasylol). , 1989, The Journal of thoracic and cardiovascular surgery.

[13]  L. Edmunds,et al.  Loss of platelet fibrinogen receptors during clinical cardiopulmonary bypass. , 1989, The Journal of thoracic and cardiovascular surgery.

[14]  W. Dietrich,et al.  Reduction of blood utilization during myocardial revascularization. , 1989, The Journal of thoracic and cardiovascular surgery.

[15]  N. Starr,et al.  Heparin-associated thrombocytopenia: management of patients for open heart surgery. Case reports describing the use of iloprost. , 1988, Anesthesiology.

[16]  D. Bichet,et al.  1-Desamino[8-D-Arginine]Vasopressin (dDAVP) Decreases Blood Pressure and Increases Pulse Rate in Normal Individuals , 1988, Thrombosis and Haemostasis.

[17]  J. Kauten,et al.  Revascularization after thrombolytic therapy for acute myocardial infarction: an analysis of 573 patients. , 1988, The Annals of thoracic surgery.

[18]  R. Weisel,et al.  Dipyridamole preserved platelets and reduced blood loss after cardiopulmonary bypass. , 1988, The Journal of thoracic and cardiovascular surgery.

[19]  J. Spivak,et al.  Effect of repeated whole blood donations on serum immunoreactive erythropoietin levels in autologous donors. , 1988, JAMA.

[20]  J. Paramo,et al.  Does desmopressin acetate reduce blood loss after surgery in patients on cardiopulmonary bypass? , 1988, Circulation.

[21]  G. Gravlee,et al.  Variability of the activated coagulation time. , 1988, Anesthesia and analgesia.

[22]  J. Caprini,et al.  Decreased Platelet Number and Function and Increased Fibrinolysis Contribute to Postoperative Bleeding in Cardiopulmonary Bypass Patients , 1988, Thrombosis and Haemostasis.

[23]  L. Muhlbaier,et al.  Immediate versus delayed coronary grafting after streptokinase treatment. Postoperative blood loss and clinical results. , 1988, The Journal of thoracic and cardiovascular surgery.

[24]  L. Goodnough,et al.  Autologous blood donation for elective surgery. Effect on physician transfusion behavior. , 1987, JAMA.

[25]  W. van Oeveren,et al.  Effects of aprotinin on hemostatic mechanisms during cardiopulmonary bypass. , 1987, The Annals of thoracic surgery.

[26]  C. Akins,et al.  Diminished anticoagulant response to heparin in patients undergoing coronary artery bypass grafting. , 1987, The Journal of thoracic and cardiovascular surgery.

[27]  G. Gravlee,et al.  Predicting the pharmacodynamics of heparin: a clinical evaluation of the Hepcon System 4. , 1987, Journal of cardiothoracic anesthesia.

[28]  H. Kreuzer,et al.  Influence of heparin, aspirin, streptokinase and factor VIII (AHF) on amorphous electron-dense substance, a mediator of platelet and thrombus adhesion in vivo. , 1987, Haemostasis.

[29]  J. Lowe,et al.  Management of patients with heparin-associated thrombocytopenia and thrombosis requiring cardiac surgery. , 1987, The Annals of thoracic surgery.

[30]  W. Daggett,et al.  Transfusion of predonated autologous blood in elective cardiac surgery. , 1987, The Annals of thoracic surgery.

[31]  T. Bateman,et al.  Treatment of severe platelet dysfunction and hemorrhage after cardiopulmonary bypass: reduction in blood product usage with desmopressin. , 1987, Journal of the American College of Cardiology.

[32]  R. Strauss,et al.  Predeposited autologous blood for elective surgery. A national multicenter study. , 1987, The New England journal of medicine.

[33]  C. Fisher,et al.  Comparison of equimolar concentrations of iloprost, prostacyclin, and prostaglandin E1 on human platelet function. , 1987, The Journal of laboratory and clinical medicine.

[34]  R. Weintraub,et al.  Treatment with desmopressin acetate to reduce blood loss after cardiac surgery. A double-blind randomized trial. , 1986, The New England journal of medicine.

[35]  P. Belcher,et al.  Reduction of blood use in surgery for coronary artery disease. , 1986, The Journal of cardiovascular surgery.

[36]  E. E. Glazer,et al.  Utilization and effectiveness of a hospital autologous preoperative blood donor program , 1986, Transfusion.

[37]  R. Weintraub,et al.  Treatment with Desmopressin Acetate to Reduce Blood Loss after Cardiac Surgery , 1986 .

[38]  R. S. Mitchell,et al.  A prospective, randomized study of the effects of prostacyclin on platelets and blood loss during coronary bypass operations. , 1986, The Journal of thoracic and cardiovascular surgery.

[39]  C. Fisher,et al.  THE USE OF ILOPROST(ZK36374) TO PERMIT CARDIOPULMONARY BYPASS IN 2 PATIENTS WITH HEPARIN-INDUCED THROMBOCYTOPENIA , 1985 .

[40]  R. Wilson,et al.  Hemostasis Changes During Cardiopulmonary Bypass Surgery , 1985, Seminars in thrombosis and hemostasis.

[41]  R. Bick.  Hemostasis Defects Associated with Cardiac Surgery, Prosthetic Devices, and Other Extracorporeal Circuits , 1985, Seminars in thrombosis and hemostasis.

[42]  L. Brace,et al.  An Objective Assessment of the Interaction of Heparin and Its Fractions with Human Platelets , 1985, Seminars in thrombosis and hemostasis.

[43]  L. Cohn,et al.  Disadvantages of prostacyclin infusion during cardiopulmonary bypass: a double-blind study of 50 patients having coronary revascularization. , 1984, The Annals of thoracic surgery.

[44]  G. Chung,et al.  Fresh frozen plasma: a solution to heparin resistance during cardiopulmonary bypass. , 1984, The Annals of thoracic surgery.

[45]  M. Cheang,et al.  SHORTENING OF BLEEDING TIME BY 1-DEAMINO-8-D-ARGININE VASOPRESSIN IN VARIOUS BLEEDING DISORDERS , 1984, The Lancet.

[46]  S. Phillips,et al.  Immediate coronary bypass following failed streptokinase infusion in evolving myocardial infarction. , 1984, The Journal of thoracic and cardiovascular surgery.

[47]  B. Bull,et al.  Platelet Involvement in the Activated Coagulation Time of Heparinized Blood , 1984, Anesthesia and analgesia.

[48]  J. A. Cohen.  Activated Coagulation Time Method for Control of Heparin is Reliable during Cardiopulmonary Bypass , 1984, Anesthesiology.

[49]  R. Weinstein,et al.  Acquired immunodeficiency syndrome (AIDS) associated with transfusions. , 1984, The New England journal of medicine.

[50]  F. Hehrlein,et al.  Prostacyclin in aortocoronary bypass surgery: a double-blind, placebo-controlled study. , 1983, Thrombosis research.

[51]  J. Ankeney,et al.  Activated Coagulation and Activated Partial Thromboplastin Times in Assessment and Reversal of Heparin‐Induced Anticoagulation for Cardiopulmonary Bypass , 1983, Anesthesia and analgesia.

[52]  D. Goldfinger,et al.  Safety of autologous blood donation prior to elective surgery for a variety of potentially “high‐risk” patients , 1983, Transfusion.

[53]  S. Thomas,et al.  Heparin resistance during cardiopulmonary bypass. The role of heparin pretreatment. , 1983, The Journal of thoracic and cardiovascular surgery.

[54]  D. Silver,et al.  Heparin-induced thrombocytopenia with thrombosis and hemorrhage. , 1981, Archives of surgery.

[55]  M. G. Lötter,et al.  Kinetics and sites of sequestration of indium 111-labeled human platelets during cardiopulmonary bypass. , 1981, The Journal of thoracic and cardiovascular surgery.

[56]  H. Takahashi.  Studies on the pathophysiology and treatment of von Willebrand's disease. V. Properties of factor VIII after DDAVP infusion in variant von Willebrand's disease. , 1981, Thrombosis research.

[57]  Packham Ma,et al.  Pharmacology of platelet-affecting drugs. , 1980 .

[58]  E. Hessel,et al.  Mechanism of abnormal bleeding in patients undergoing cardiopulmonary bypass: acquired transient platelet dysfunction associated with selective alpha-granule release. , 1980, Blood.

[59]  H. Soloway,et al.  Heparin anticoagulation during cardiopulmonary bypass in an antithrombin-III deficient patient. Implications relative to the etiology of heparin rebound. , 1980, American journal of clinical pathology.

[60]  C. J. Lambert,et al.  The Treatment of Postperfusion Bleeding Using ε-Aminocaproic Acid, Cryoprecipitate, Fresh-Frozen Plasma, and Protamine Sulfate , 1979 .

[61]  F. Loop,et al.  Blood conservation during myocardial revascularization. , 1979, The Annals of thoracic surgery.

[62]  R. Colman,et al.  Preservation of Human Platelets with Prostaglandin Ei during in Vitro Simulation of Cardiopulmonary Bypass , 1979, Circulation research.

[63]  C. Kisker,et al.  Adequate anticoagulation during cardiopulmonary bypass determined by activated clotting time and the appearance of fibrin monomer. , 1978, The Annals of thoracic surgery.

[64]  T. Barrowcliffe,et al.  Antithrombin III and heparin. , 1978, British medical bulletin.

[65]  J. Verska.  Control of heparinization by activated clotting time during bypass with improved postoperative hemostasis. , 1977, The Annals of thoracic surgery.

[66]  F. Bachmann,et al.  The hemostatic mechanism after open-heart surgery. II. Frequency of abnormal platelet functions during and after extracorporeal circulation. , 1975, The Journal of thoracic and cardiovascular surgery.

[67]  F. Bachmann,et al.  The hemostatic mechanism after open-heart surgery. I. Studies on plasma coagulation factors and fibrinolysis in 512 patients after extracorporeal circulation. , 1975, The Journal of thoracic and cardiovascular surgery.

[68]  B. Bull,et al.  Heparin therapy during extracorporeal circulation. II. The use of a dose-response curve to individualize heparin and protamine dosage. , 1975, The Journal of thoracic and cardiovascular surgery.

[69]  B. Bull,et al.  Heparin therapy during extracorporeal circulation. I. Problems inherent in existing heparin protocols. , 1975, The Journal of thoracic and cardiovascular surgery.

[70]  N. Mills,et al.  Fresh Autologous Blood Transfusions with Extracorporeal Circulation , 1973, Annals of surgery.

[71]  M. Buckley,et al.  Transfusion of fresh autologous blood in open-heart surgery. A method for reducing bank blood requirements. , 1972, The Journal of thoracic and cardiovascular surgery.

[72]  P. Hattersley.  Activated coagulation time of whole blood. , 1966, JAMA.

[73]  S. Effert,et al.  Late results after intracoronary thrombolysis and early bypass grafting for acute myocardial infarction. , 1989, The Journal of thoracic and cardiovascular surgery.

[74]  G. Gravlee,et al.  Early anticoagulation peak and rapid distribution after intravenous heparin. , 1988, Anesthesiology.

[75]  S. Ferraris,et al.  Preoperative aspirin ingestion increases operative blood loss after coronary artery bypass grafting. , 1988, The Annals of thoracic surgery.

[76]  G. Taylor,et al.  Early operative intervention after thrombolytic therapy for acute myocardial infarction. , 1985, Journal of vascular surgery.

[77]  M. Laato,et al.  Use of activated clotting time to monitor anticoagulation during cardiac surgery. , 1984, Scandinavian journal of thoracic and cardiovascular surgery.

[78]  高橋 芳右.  Studies on the pathophysiology and treatment of von Willebrand's disease , 1984 .

[79]  F. Spencer,et al.  Lack of correlation between activated clotting time and plasma heparin during cardiopulmonary bypass. , 1981, Annals of surgery.

[80]  M. Orr.  Autotransfusion: the use of washed red cells as an adjunct to component therapy. , 1978, Surgery.

[81]  N. Baumslag.  Letter: Lead poisoning. , 1975, Lancet.